Our website (this “Site”) uses cookies to distinguish you from other users of our Site. This helps us provide you with a good experience when you browse our Site ... Cookie Policy.
Accept
LOADING
Here’s why analysts believe ₹100 crore IPO of Dr Trust’s parent Nureca is a ‘sizeable’ opportunity
Economics
18 February 2021 10:59 AM
The ₹100 crore initial public offering (IPO) of healthcare and wellness products distributor Nureca Limited is now open for public subscription. The issue will remain open till February 17, making it the sixth IPO of 2021.